ARVEE

Arvee Laboratories (India) Share Price

 

Stock Hit Upper Circuit

 

Start SIP in ARVEE

Start SIP

Performance

  • Low
  • ₹177
  • High
  • ₹198
  • 52 Week Low
  • ₹127
  • 52 Week High
  • ₹233
  • Open Price₹177
  • Previous Close₹165
  • Volume95,260

Investment Returns

  • Over 1 Month + 23.58%
  • Over 3 Month + 28.94%
  • Over 6 Month + 11.11%
  • Over 1 Year + 15.57%

Smart Investing Starts Here Start SIP with Arvee Laboratories (India) for Steady Growth!

Invest Now

Arvee Laboratories (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 539.7
  • PEG Ratio
  • -6.6
  • Market Cap Cr
  • 218
  • P/B Ratio
  • Average True Range
  • 10.21
  • EPS
  • 0.37
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.67
  • RSI
  • 76.18
  • MFI
  • 98.67

Arvee Laboratories (India) Financials

Arvee Laboratories (India) Technicals

EMA & SMA

Current Price
₹197.48
+ 32.86 (19.96%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹166.64
  • 50 Day
  • ₹165.06
  • 100 Day
  • ₹165.12
  • 200 Day
  • ₹165.07

Resistance and Support

190.67 Pivot Speed
  • R3 224.90
  • R2 211.22
  • R1 204.35
  • S1 183.80
  • S2 170.12
  • S3 163.25

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Arvee Laboratories (India) has an operating revenue of Rs. 26.29 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 7% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 0% and 2% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 23% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 128 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Arvee Laboratories (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-12 Quarterly Results
2025-05-09 Audited Results & Others To consider Other business matters.
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results & Others To consider other business matters.

Arvee Laboratories (India) F&O

Arvee Laboratories (India) Shareholding Pattern

73.5%
26.19%
0.31%

About Arvee Laboratories (India)

  • NSE Symbol
  • ARVEE
  • BSE Symbol
  • Managing Director
  • Mr. Shalin Sudhakarbhai Patel
  • ISIN
  • INE006Z01016

Similar Stocks to Arvee Laboratories (India)

Arvee Laboratories (India) FAQs

Arvee Laboratories (India) share price is ₹197 As on 06 December, 2025 | 23:53

The Market Cap of Arvee Laboratories (India) is ₹217.6 Cr As on 06 December, 2025 | 23:53

The P/E ratio of Arvee Laboratories (India) is 539.7 As on 06 December, 2025 | 23:53

The PB ratio of Arvee Laboratories (India) is 7 As on 06 December, 2025 | 23:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23